Human CX3CL1/ABCD-3/C3Xkine ORF/cDNA clone-Lentivirus particle (NM_002996.5)
Cat. No.: vGMLP001884
Pre-made Human CX3CL1/ABCD-3/C3Xkine Lentiviral expression plasmid for CX3CL1 lentivirus packaging, CX3CL1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
CX3CL1/ABCD-3 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLP001884 | Human CX3CL1 Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLP001884 |
| Gene Name | CX3CL1 |
| Accession Number | NM_002996.5 |
| Gene ID | 6376 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 1194 bp |
| Gene Alias | ABCD-3,C3Xkine,CXC3,CXC3C,fractalkine,neurotactin,NTN,NTT,SCYD1 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGCTCCGATATCTCTGTCGTGGCTGCTCCGCTTGGCCACCTTCTGCCATCTGACTGTCCTGCTGGCTGGACAGCACCACGGTGTGACGAAATGCAACATCACGTGCAGCAAGATGACATCAAAGATACCTGTAGCTTTGCTCATCCACTATCAACAGAACCAGGCATCATGCGGCAAACGCGCAATCATCTTGGAGACGAGACAGCACAGGCTGTTCTGTGCCGACCCGAAGGAGCAATGGGTCAAGGACGCGATGCAGCATCTGGACCGCCAGGCTGCTGCCCTAACTCGAAATGGCGGCACCTTCGAGAAGCAGATCGGCGAGGTGAAGCCCAGGACCACCCCTGCCGCCGGGGGAATGGACGAGTCTGTGGTCCTGGAGCCCGAAGCCACAGGCGAAAGCAGTAGCCTGGAGCCGACTCCTTCTTCCCAGGAAGCACAGAGGGCCCTGGGGACCTCCCCAGAGCTGCCGACGGGCGTGACTGGTTCCTCAGGGACCAGGCTCCCCCCGACGCCAAAGGCTCAGGATGGAGGGCCTGTGGGCACGGAGCTTTTCCGAGTGCCTCCCGTCTCCACTGCCGCCACGTGGCAGAGTTCTGCTCCCCACCAACCTGGGCCCAGCCTCTGGGCTGAGGCAAAGACCTCTGAGGCCCCGTCCACCCAGGACCCCTCCACCCAGGCCTCCACTGCGTCCTCCCCAGCCCCAGAGGAGAATGCTCCGTCTGAAGGCCAGCGTGTGTGGGGTCAGGGACAGAGCCCCAGGCCAGAGAACTCTCTGGAGCGGGAGGAGATGGGTCCCGTGCCAGCGCACACGGATGCCTTCCAGGACTGGGGGCCTGGCAGCATGGCCCACGTCTCTGTGGTCCCTGTCTCCTCAGAAGGGACCCCCAGCAGGGAGCCAGTGGCTTCAGGCAGCTGGACCCCTAAGGCTGAGGAACCCATCCATGCCACCATGGACCCCCAGAGGCTGGGCGTCCTTATCACTCCTGTCCCTGACGCCCAGGCTGCCACCCGGAGGCAGGCGGTGGGGCTGCTGGCCTTCCTTGGCCTCCTCTTCTGCCTGGGGGTGGCCATGTTCACCTACCAGAGCCTCCAGGGCTGCCCTCGAAAGATGGCAGGAGAGATGGCGGAGGGCCTTCGCTACATCCCCCGGAGCTGTGGTAGTAATTCATATGTCCTGGTGCCCGTGTGA |
| ORF Protein Sequence | MAPISLSWLLRLATFCHLTVLLAGQHHGVTKCNITCSKMTSKIPVALLIHYQQNQASCGKRAIILETRQHRLFCADPKEQWVKDAMQHLDRQAAALTRNGGTFEKQIGEVKPRTTPAAGGMDESVVLEPEATGESSSLEPTPSSQEAQRALGTSPELPTGVTGSSGTRLPPTPKAQDGGPVGTELFRVPPVSTAATWQSSAPHQPGPSLWAEAKTSEAPSTQDPSTQASTASSPAPEENAPSEGQRVWGQGQSPRPENSLEREEMGPVPAHTDAFQDWGPGSMAHVSVVPVSSEGTPSREPVASGSWTPKAEEPIHATMDPQRLGVLITPVPDAQAATRRQAVGLLAFLGLLFCLGVAMFTYQSLQGCPRKMAGEMAEGLRYIPRSCGSNSYVLVPV |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-ab-461 | Pre-Made Quetmolimab biosimilar, Whole mAb, Anti-CX3CL1 Antibody: Anti-ABCD-3/C3Xkine/CXC3/CXC3C/NTN/NTT/SCYD1/fractalkine/neurotactin therapeutic antibody |
| Target Antibody | GM-Tg-g-T34405-Ab | Anti-X3CL1/ CX3CL1/ ABCD-3 monoclonal antibody |
| Target Antigen | GM-Tg-g-T34405-Ag | CX3CL1 VLP (virus-like particle) |
| Cytokine | cks-Tg-g-GM-T34405 | chemokine (C-X3-C motif) ligand 1 (CX3CL1) protein & antibody |
| ORF Viral Vector | pGMLP001884 | Human CX3CL1 Lentivirus plasmid |
| ORF Viral Vector | pGMLV000860 | Human CX3CL1 Lentivirus plasmid |
| ORF Viral Vector | vGMLP001884 | Human CX3CL1 Lentivirus particle |
| ORF Viral Vector | vGMLV000860 | Human CX3CL1 Lentivirus particle |
Target information
| Target ID | GM-T34405 |
| Target Name | CX3CL1 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
6376 |
| Gene ID |
101084670 (Felis catus), 102150350 (Equus caballus), 20312 (Mus musculus), 487265 (Canis lupus familiaris) 517354 (Bos taurus), 574225 (Macaca mulatta), 6376 (Homo sapiens), 89808 (Rattus norvegicus) |
| Gene Symbols & Synonyms | CX3CL1,Cx3cl1,FK,CX3C,Cxc3,Scyd1,ABCD-3,D8Bwg0439e,NTN,NTT,CXC3,CXC3C,SCYD1,C3Xkine,fractalkine,neurotactin,Cx3c |
| Target Alternative Names | ABCD-3,C-X3-C motif chemokine 1,C3Xkine,CX3C,CX3C membrane-anchored chemokine,CX3CL1,CXC3,CXC3C,Cx3c,Cx3cl1,Cxc3,D8Bwg0439e,FK,Fractalkine,NTN,NTT,Neurotactin,SCYD1,Scyd1,Small-inducible cytokine D1,fractalkine,neurotactin |
| Uniprot Accession |
O35188,O55145,P78423
Additional SwissProt Accessions: O35188,P78423,O55145 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, INN Index, Cytokine Target |
| Disease | cancer |
| Disease from KEGG | Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Chemokine signaling pathway, TNF signaling pathway, Human cytomegalovirus infection |
| Gene Ensembl | ENSECAG00000031387, ENSMUSG00000031778, ENSCAFG00845003350, ENSBTAG00000024869, ENSMMUG00000059578, ENSG00000006210 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


